Key result
Ischemic cardiomyopathy exhibits a ~38% steeper APDR slope versus structurally normal left ventricles.
Why the study?
Patients with ICMP are at high risk for malignant arrhythmias, but the electrophysiological properties of their non-infarcted myocardium remain largely unknown.
Does the non-infarcted myocardium of patients with ischemic cardiomyopathy exhibit pro-arrhythmic electrophysiological remodeling compared to structurally normal left ventricles?
Observational (n=22)
No
Does the non-infarcted myocardium of patients with ischemic cardiomyopathy exhibit pro-arrhythmic electrophysiological remodeling compared to structurally normal left ventricles?
Effect estimate: 38% steeper
p-value: p=0.002
Patients with ischemic cardiomyopathy exhibit a steeper action potential duration restitution slope in non-infarcted myocardium, which underlies a greater arrhythmogenic propensity.
May heighten arrhythmia risk via non-infarcted remodeling; hypothesis-generating and requires prospective validation before clinical use.
Rationale Patients with ischemic cardiomyopathy (ICMP) are at high risk for malignant arrhythmias, largely due to electrophysiological remodeling of the non-infarcted myocardium. The electrophysiological properties of the non-infarcted myocardium of patients with ICMP remain largely unknown. Objectives To assess the pro-arrhythmic behavior of non-infarcted myocardium in ICMP patients and couple computational simulations with machine learning to establish a methodology for the development of disease-specific action potential models based on clinically measured action potential duration restitution (APDR) data. Methods and Results We enrolled 22 patients undergoing left-sided ablation (10 ICMP) and compared APDRs between ICMP and structurally normal left ventricles (SNLVs). APDRs were clinically assessed with a decremental pacing protocol. Using genetic algorithms (GAs), we constructed populations of action potential models that incorporate the cohort-specific APDRs. The variability in the populations of ICMP and SNLV models was captured by clustering models based on their similarity using unsupervised machine learning. The pro-arrhythmic potential of ICMP and SNLV models was assessed in cell- and tissue-level simulations. Clinical measurements established that ICMP patients have a steeper APDR slope compared to SNLV (by 38%, p < 0.01). In cell-level simulations, APD alternans were induced in ICMP models at a longer cycle length compared to SNLV models (385–400 vs 355 ms). In tissue-level simulations, ICMP models were more susceptible for sustained functional re-entry compared to SNLV models. Conclusion Myocardial remodeling in ICMP patients is manifested as a steeper APDR compared to SNLV, which underlies the greater arrhythmogenic propensity in these patients, as demonstrated by cell- and tissue-level simulations using action potential models developed by GAs from clinical measurements. The methodology presented here captures the uncertainty inherent to GAs model development and provides a blueprint for use in future studies aimed at evaluating electrophysiological remodeling resulting from other cardiac diseases.
No takes yet. Share an insight, caveat, or question.
Aronis et al. (2021) conducted an observational in Ischemic cardiomyopathy (n=22). Ischemic cardiomyopathy vs. Structurally normal left ventricles (SNLV) was evaluated on Action potential duration restitution (APDR) slope (38% steeper, p=0.002). Ischemic cardiomyopathy patients exhibited a 38% steeper action potential duration restitution slope compared to patients with structurally normal left ventricles (p=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: